Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

271
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
271
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

211
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
211
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

6.8K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
6.8K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

1.0K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
1.0K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

4.9K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.9K
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

289
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
289

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Revealing interactions between glutathione peroxidase 4 and phosphoinositides.

bioRxiv : the preprint server for biology·2026
Same author

Metal-ion induced coacervation of a short peptide under acidic conditions.

Soft matter·2026
Same author

The University of Kansas Cardiac Surgery Readmissions Committee: A Multidisciplinary Collaborative to Reduce Unplanned Readmissions.

Annals of thoracic surgery short reports·2026
Same author

Multidisciplinary Approach to a Symptomatic Anomalous Right Coronary Artery and Coronary Cameral Fistula in a 42-Year-Old Woman.

Annals of thoracic surgery short reports·2026
Same author

Full-Length Structure and Heme Binding in the Transcriptional Regulator HcpR.

ACS omega·2026
Same author

Red blood cell mass as a predictor of transfusion risk of packed red blood cells in cardiac surgery patients requiring cardiopulmonary bypass.

Surgery in practice and science·2025
Same journal

DeepDOX1: A Dual-Drive Framework Integrating Deep Learning and First-Principles Quantum Chemistry for Drug-Protein Affinity Prediction.

JACS Au·2026
Same journal

Catalyst-Controlled Regiodivergent C-H Olefination of Furanyl Carbamates through a Rational Approach.

JACS Au·2026
Same journal

Charting the Biosynthetic Landscape of Hybrid Polyketide-Nonribosomal Peptide-Specialized Lipids.

JACS Au·2026
Same journal

Valence-State-Dependent Surface Lattice Oxygen in CeO<sub>2</sub>‑Modified VPO Catalysts: Elucidating the Mechanism of <i>n</i>‑Butane Selective Oxidation to Maleic Anhydride.

JACS Au·2026
Same journal

Quantitative Insights into Pressure-Dependent Mass Transport and Reaction Kinetics in Electrochemical CO<sub>2</sub> Reduction.

JACS Au·2026
Same journal

3‑Methylthiopropionic Acid Kills Carbapenem-Resistant <i>Klebsiella pneumoniae</i> by Disrupting Membrane Integrity and Bioenergetics.

JACS Au·2026
See all related articles

Related Experiment Video

Updated: Sep 17, 2025

High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy
06:38

High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy

Published on: February 7, 2019

8.9K

Broad PFAS Binding with Fatty Acid Binding Protein 4 Is Enabled by Variable Binding Modes.

Aaron S Birchfield1, Faik N Musayev2,3, Abdul J Castillo1

  • 1Department of Chemistry, Virginia Commonwealth University, Richmond, Virginia 23284, United States.

JACS Au
|June 27, 2025
PubMed
Summary
This summary is machine-generated.

Human adipocyte fatty acid-binding protein 4 (FABP4) binds various per- and polyfluoroalkyl substances (PFAS), including replacements for older chemicals. Structural analysis reveals distinct binding modes, impacting protein interactions and potential metabolic regulation.

Keywords:
FABP4Fatty acid binding protein 4PFASX-ray crystallographyfluorinated ligandsper- and polyfluoroalkyl substancesprotein structure

More Related Videos

Molecular Spring Constant Analysis by Biomembrane Force Probe Spectroscopy
08:10

Molecular Spring Constant Analysis by Biomembrane Force Probe Spectroscopy

Published on: November 20, 2021

3.1K
Fluorescence-Based Measurements of Phosphatidylserine/Phosphatidylinositol 4-Phosphate Exchange Between Membranes
08:49

Fluorescence-Based Measurements of Phosphatidylserine/Phosphatidylinositol 4-Phosphate Exchange Between Membranes

Published on: March 14, 2021

4.2K

Related Experiment Videos

Last Updated: Sep 17, 2025

High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy
06:38

High Sensitivity Measurement of Transcription Factor-DNA Binding Affinities by Competitive Titration Using Fluorescence Microscopy

Published on: February 7, 2019

8.9K
Molecular Spring Constant Analysis by Biomembrane Force Probe Spectroscopy
08:10

Molecular Spring Constant Analysis by Biomembrane Force Probe Spectroscopy

Published on: November 20, 2021

3.1K
Fluorescence-Based Measurements of Phosphatidylserine/Phosphatidylinositol 4-Phosphate Exchange Between Membranes
08:49

Fluorescence-Based Measurements of Phosphatidylserine/Phosphatidylinositol 4-Phosphate Exchange Between Membranes

Published on: March 14, 2021

4.2K

Area of Science:

  • Environmental Chemistry
  • Structural Biology
  • Toxicology

Background:

  • Per- and polyfluoroalkyl substances (PFAS) are widespread environmental contaminants known to bioaccumulate.
  • The molecular mechanisms underlying PFAS interactions with biological proteins are not well understood.

Purpose of the Study:

  • To investigate the binding of various PFAS to human adipocyte fatty acid-binding protein 4 (FABP4).
  • To elucidate the structural basis of PFAS-FABP4 interactions.
  • To understand the implications of these interactions for metabolic regulation.

Main Methods:

  • X-ray crystallography was used to determine the structures of FABP4 bound to PFOA, PFDA, and PFHxDA.
  • Fluorescence competition assays were employed to measure binding affinities.

Main Results:

  • FABP4 binds a diverse range of PFAS, including newer chemicals and long-chain perfluorocarboxylic acids.
  • Three distinct binding modes were observed for PFOA, PFDA, and PFHxDA, influenced by PFAS chain length and headgroup.
  • Binding affinities were in the low micromolar range, suggesting significant interactions.

Conclusions:

  • PFAS binding to FABP4 is influenced by chemical structure and protein conformation.
  • These interactions may have implications for FABP4's role in endocrine function and metabolic regulation.
  • Structural and biochemical insights are crucial for understanding PFAS toxicology and transport.